Created at 2:48 p.m. Sep, 09, 2024
Author: mohannadkh10
Related Note: 1482978436457 2
Rationale for change

Replace old note with examples

Extra Extra
Text
What class of lipid-lowering drugs is associated with cholesterol gallstone formation?

{{c1::Fibrates}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo

OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step2_v12::#SketchySurgery::03_Hepatobiliary_Disorders::01_Gallbladder_&_Bile_Ducts::01_Cholelithiasis_and_Acute_Calculus_Cholecystitis #AK_Step2_v12::#B&B::06_GI::03_Biliary_Tree_and_Pancreas::02_Gallstone_Disease::Extra #PANCE::EOR::Family_med #AK_Step1_v12::#FirstAid::07_Cardiovascular::05_Pharm::10_Lipid-lowering_Agents::*Bile_Acid_Resins #PANCE::EOR::IM !AK_UpdateTags::AnKing_Image::Ahmed #AK_Step1_v12::#UWorld::Step::67 #AK_Step1_v12::#B&B::09_GI::03_Clinical_Gastroenterology::07_Gallstones #AK_Step1_v12::#Pixorize::03_Pharmacology::06_Cardiovascular_Pharm::17_Fibrates #AK_Step1_v12::#UWorld::Step::164 #AK_Step1_v12::#Pathoma::11_Exocrine,Pancreas,Gallbladder,&Liver::02_Gallbladder_&_Biliary_Tract #AK_Step1_v12::^Systems::GI::pathology #AK_Step1_v12::#UWorld::COMLEX::23277 #AK_Step2_v12::#SketchySurgery::03_Hepatobiliary_Disorders::01_Gallbladder_&_Bile_Ducts::03_Choledocholithiasis #AK_Step1_v12::#OME::PreClinical::Cardiac #AK_Step1_v12::#AMBOSS::_Pa5hk #AK_Step1_v12::#FirstAid::09_Gastrointestinal::04_Pathology::50_Cholelithiasis_and_related_pathologies::*Cholelithiasis::Cholesterol_Gallstone #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::10_Bile_Acid_Resins #AK_Step1_v12::^Other::^HighYield::1-HighYield #PANCE::CARDIO::lipid_disorders #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_GI::GI_Pathology !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-GI::GI-Pathology #AK_Step1_v12::#Physeo::11_Pathology::06_Gastrointestinal_Pathology::11_Gallbladder_Biliary_Tract #AK_Step1_v12::#UWorld::COMLEX::23181 #AK_Step1_v12::#Bootcamp::Biochemistry::09_Lipid_Metabolism::09_Hyperlipidemia_Pharmacology #AK_Step1_v12::#Pixorize::03_Pharmacology::22_Cardiovascular_(New)::12_Fibrates #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#AMBOSS::r0afhQ #AK_Step1_v12::#FirstAid::07_Cardiovascular::05_Pharm::10_Lipid-lowering_Agents::*Fibrates #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::12_Fibrates #AK_Step1_v12::#Bootcamp::Gastroenterology::07_Pancreatic_and_Biliary_Pathology::05_Gallstones #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::02_Dyslipidemia_Drugs::03_Fibrates_&_Niacin